|
|
|
Volumn 28, Issue 10, 2006, Pages 788-790
|
|
Multicenter phase II study of modified FOLFIRI regimen in the advanced colorectal cancer patient refractory to fluoropyrimidine and oxaliplatin
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5-FLUOROPYRIMIDINE;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROPYRIMIDINE;
FLUOROURACIL;
FOLINIC ACID;
IFL PROTOCOL;
OXALIPLATIN;
PLATINUM COMPLEX;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COLON TUMOR;
DIARRHEA;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NAUSEA;
NEUTROPENIA;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RECTUM TUMOR;
REMISSION;
TREATMENT FAILURE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLONIC NEOPLASMS;
DIARRHEA;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NAUSEA;
NEOPLASM STAGING;
NEUTROPENIA;
ORGANOPLATINUM COMPOUNDS;
PROSPECTIVE STUDIES;
PYRIMIDINES;
RECTAL NEOPLASMS;
REMISSION INDUCTION;
TREATMENT FAILURE;
|
|
EID: 39049133010
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
